Research
Hormonal
Magnesium deficiency contributes to insulin resistance and type 2 diabetes through impaired insulin signaling, specifically by altering the PI3K/Akt pathway and KATP channel regulation in pancreatic beta cells.
Maintaining adequate magnesium levels is crucial for proper insulin function. Low magnesium disrupts the cellular machinery that allows insulin to work, contributing to the development of type 2 diabetes.
GoodSupportsHIGH confidence
Low intracellular Mg2+ impairs cell responsiveness to insulin, because low intracellular Mg2+ alters the tyrosine-kinase activity of the insulin receptor (INSR)... Mg2+ and Mg-ATP complex are key regulators of the PI3K/Akt kinase pathway downstream to the INSR.
Why this rating
Supported by detailed molecular pathways and cited studies, though it is a review paper summarizing mechanisms.
Source
Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes
Gabriele Piuri et al. · Nutrients · 2021
DOI 10.3390/nu13020320
narrative_reviewCited 223×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →